nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—PTGS2—melanoma	0.708	1	CbGaD
Salicylate-sodium—Skin papilloma—Vemurafenib—melanoma	0.00879	0.0449	CcSEcCtD
Salicylate-sodium—Localized exfoliation—Bleomycin—melanoma	0.00644	0.033	CcSEcCtD
Salicylate-sodium—PTGS2—leg—melanoma	0.00482	0.162	CbGeAlD
Salicylate-sodium—Acetylsalicylic acid—HSPA5—melanoma	0.00467	0.404	CrCbGaD
Salicylate-sodium—Bronchopneumonia—Docetaxel—melanoma	0.00446	0.0228	CcSEcCtD
Salicylate-sodium—PTGS2—hindlimb—melanoma	0.00431	0.145	CbGeAlD
Salicylate-sodium—Clotting—Temozolomide—melanoma	0.0041	0.021	CcSEcCtD
Salicylate-sodium—PTGS2—appendage—melanoma	0.0037	0.124	CbGeAlD
Salicylate-sodium—PTGS2—skin epidermis—melanoma	0.00307	0.104	CbGeAlD
Salicylate-sodium—PTGS1—endothelium—melanoma	0.00233	0.0786	CbGeAlD
Salicylate-sodium—PTGS2—endothelium—melanoma	0.00223	0.0751	CbGeAlD
Salicylate-sodium—Burning sensation—Carmustine—melanoma	0.00218	0.0112	CcSEcCtD
Salicylate-sodium—PTGS1—blood vessel—melanoma	0.00215	0.0725	CbGeAlD
Salicylate-sodium—Coagulopathy—Dactinomycin—melanoma	0.00208	0.0106	CcSEcCtD
Salicylate-sodium—Necrosis—Dactinomycin—melanoma	0.00206	0.0105	CcSEcCtD
Salicylate-sodium—PTGS2—blood vessel—melanoma	0.00206	0.0693	CbGeAlD
Salicylate-sodium—Duodenal ulcer—Docetaxel—melanoma	0.00201	0.0103	CcSEcCtD
Salicylate-sodium—Extravasation—Bleomycin—melanoma	0.00199	0.0102	CcSEcCtD
Salicylate-sodium—Tenderness—Bleomycin—melanoma	0.00199	0.0102	CcSEcCtD
Salicylate-sodium—Necrosis—Carmustine—melanoma	0.00193	0.00987	CcSEcCtD
Salicylate-sodium—Acetylsalicylic acid—TP53—melanoma	0.00192	0.166	CrCbGaD
Salicylate-sodium—Abscess—Carmustine—melanoma	0.00191	0.00979	CcSEcCtD
Salicylate-sodium—Coagulopathy—Temozolomide—melanoma	0.00188	0.00962	CcSEcCtD
Salicylate-sodium—Extravasation—Dactinomycin—melanoma	0.00186	0.00949	CcSEcCtD
Salicylate-sodium—Ulcer—Bleomycin—melanoma	0.00183	0.00938	CcSEcCtD
Salicylate-sodium—Hypocalcaemia—Dactinomycin—melanoma	0.00177	0.00904	CcSEcCtD
Salicylate-sodium—Extravasation—Carmustine—melanoma	0.00174	0.00888	CcSEcCtD
Salicylate-sodium—Ulcer—Dactinomycin—melanoma	0.00171	0.00875	CcSEcCtD
Salicylate-sodium—Skin exfoliation—Bleomycin—melanoma	0.00166	0.00847	CcSEcCtD
Salicylate-sodium—Hearing impaired—Temozolomide—melanoma	0.00154	0.00787	CcSEcCtD
Salicylate-sodium—Oesophagitis—Dactinomycin—melanoma	0.00148	0.00756	CcSEcCtD
Salicylate-sodium—Phlebitis—Bleomycin—melanoma	0.00146	0.00748	CcSEcCtD
Salicylate-sodium—Skin exfoliation—Carmustine—melanoma	0.00145	0.0074	CcSEcCtD
Salicylate-sodium—Intestinal obstruction—Docetaxel—melanoma	0.00143	0.0073	CcSEcCtD
Salicylate-sodium—Heartburn—Docetaxel—melanoma	0.00141	0.00723	CcSEcCtD
Salicylate-sodium—Disorientation—Bleomycin—melanoma	0.00141	0.0072	CcSEcCtD
Salicylate-sodium—Sepsis—Dactinomycin—melanoma	0.0014	0.00718	CcSEcCtD
Salicylate-sodium—Burning sensation—Docetaxel—melanoma	0.0014	0.00717	CcSEcCtD
Salicylate-sodium—Skin exfoliation—Temozolomide—melanoma	0.0014	0.00715	CcSEcCtD
Salicylate-sodium—Phlebitis—Dactinomycin—melanoma	0.00136	0.00697	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Vemurafenib—melanoma	0.00136	0.00696	CcSEcCtD
Salicylate-sodium—Sepsis—Carmustine—melanoma	0.00131	0.00672	CcSEcCtD
Salicylate-sodium—Cerebrovascular accident—Bleomycin—melanoma	0.00129	0.00657	CcSEcCtD
Salicylate-sodium—Phlebitis—Carmustine—melanoma	0.00128	0.00653	CcSEcCtD
Salicylate-sodium—Erythema—Vemurafenib—melanoma	0.00125	0.0064	CcSEcCtD
Salicylate-sodium—Swelling—Carmustine—melanoma	0.00125	0.00637	CcSEcCtD
Salicylate-sodium—Necrosis—Docetaxel—melanoma	0.00124	0.00634	CcSEcCtD
Salicylate-sodium—Dysgeusia—Vemurafenib—melanoma	0.00123	0.00627	CcSEcCtD
Salicylate-sodium—Lethargy—Dactinomycin—melanoma	0.0012	0.00613	CcSEcCtD
Salicylate-sodium—Deafness—Temozolomide—melanoma	0.00119	0.00608	CcSEcCtD
Salicylate-sodium—Extravasation—Docetaxel—melanoma	0.00112	0.00571	CcSEcCtD
Salicylate-sodium—Bronchospasm—Bleomycin—melanoma	0.00107	0.00548	CcSEcCtD
Salicylate-sodium—Oliguria—Docetaxel—melanoma	0.00106	0.0054	CcSEcCtD
Salicylate-sodium—Mesalazine—PPARG—melanoma	0.00103	0.0894	CrCbGaD
Salicylate-sodium—Hearing impaired—Docetaxel—melanoma	0.00102	0.00523	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Vemurafenib—melanoma	0.00102	0.00523	CcSEcCtD
Salicylate-sodium—Dysphagia—Dactinomycin—melanoma	0.00102	0.00519	CcSEcCtD
Salicylate-sodium—Infection—Vemurafenib—melanoma	0.00102	0.00519	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Carmustine—melanoma	0.001	0.00512	CcSEcCtD
Salicylate-sodium—PTGS1—skin of body—melanoma	0.000996	0.0336	CbGeAlD
Salicylate-sodium—Dehydration—Temozolomide—melanoma	0.000988	0.00505	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Temozolomide—melanoma	0.000967	0.00495	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Bleomycin—melanoma	0.000957	0.00489	CcSEcCtD
Salicylate-sodium—Hypotension—Vemurafenib—melanoma	0.000955	0.00488	CcSEcCtD
Salicylate-sodium—PTGS2—skin of body—melanoma	0.000952	0.0321	CbGeAlD
Salicylate-sodium—Myocardial infarction—Bleomycin—melanoma	0.000952	0.00487	CcSEcCtD
Salicylate-sodium—Dysphagia—Carmustine—melanoma	0.00095	0.00486	CcSEcCtD
Salicylate-sodium—Skin exfoliation—Docetaxel—melanoma	0.000929	0.00475	CcSEcCtD
Salicylate-sodium—Abdominal distension—Temozolomide—melanoma	0.000925	0.00473	CcSEcCtD
Salicylate-sodium—Fluid retention—Docetaxel—melanoma	0.000924	0.00473	CcSEcCtD
Salicylate-sodium—Dysphagia—Temozolomide—melanoma	0.000918	0.0047	CcSEcCtD
Salicylate-sodium—PTGS1—mammalian vulva—melanoma	0.000909	0.0306	CbGeAlD
Salicylate-sodium—Sweating increased—Temozolomide—melanoma	0.000895	0.00458	CcSEcCtD
Salicylate-sodium—Oesophagitis—Docetaxel—melanoma	0.00089	0.00455	CcSEcCtD
Salicylate-sodium—Decreased appetite—Vemurafenib—melanoma	0.000888	0.00454	CcSEcCtD
Salicylate-sodium—Bronchitis—Temozolomide—melanoma	0.000883	0.00452	CcSEcCtD
Salicylate-sodium—Fatigue—Vemurafenib—melanoma	0.000881	0.00451	CcSEcCtD
Salicylate-sodium—Constipation—Vemurafenib—melanoma	0.000874	0.00447	CcSEcCtD
Salicylate-sodium—Lightheadedness—Docetaxel—melanoma	0.000871	0.00445	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Bleomycin—melanoma	0.000867	0.00443	CcSEcCtD
Salicylate-sodium—Sepsis—Docetaxel—melanoma	0.000845	0.00432	CcSEcCtD
Salicylate-sodium—Weight increased—Temozolomide—melanoma	0.000836	0.00427	CcSEcCtD
Salicylate-sodium—Renal failure—Carmustine—melanoma	0.000833	0.00426	CcSEcCtD
Salicylate-sodium—Phlebitis—Docetaxel—melanoma	0.00082	0.0042	CcSEcCtD
Salicylate-sodium—Hepatitis—Dactinomycin—melanoma	0.000813	0.00416	CcSEcCtD
Salicylate-sodium—Body temperature increased—Vemurafenib—melanoma	0.000808	0.00413	CcSEcCtD
Salicylate-sodium—Swelling—Docetaxel—melanoma	0.000801	0.0041	CcSEcCtD
Salicylate-sodium—Deafness—Docetaxel—melanoma	0.00079	0.00404	CcSEcCtD
Salicylate-sodium—Cardiac failure congestive—Docetaxel—melanoma	0.000779	0.00399	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Dactinomycin—melanoma	0.000769	0.00393	CcSEcCtD
Salicylate-sodium—Erythema—Bleomycin—melanoma	0.000759	0.00388	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Carmustine—melanoma	0.000757	0.00387	CcSEcCtD
Salicylate-sodium—Hallucination—Carmustine—melanoma	0.000757	0.00387	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Vemurafenib—melanoma	0.000753	0.00385	CcSEcCtD
Salicylate-sodium—Renal impairment—Docetaxel—melanoma	0.000743	0.0038	CcSEcCtD
Salicylate-sodium—Hepatitis—Temozolomide—melanoma	0.000735	0.00376	CcSEcCtD
Salicylate-sodium—Asthenia—Vemurafenib—melanoma	0.000733	0.00375	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Temozolomide—melanoma	0.000732	0.00374	CcSEcCtD
Salicylate-sodium—Hallucination—Temozolomide—melanoma	0.000732	0.00374	CcSEcCtD
Salicylate-sodium—Pruritus—Vemurafenib—melanoma	0.000723	0.0037	CcSEcCtD
Salicylate-sodium—Lethargy—Docetaxel—melanoma	0.000721	0.00369	CcSEcCtD
Salicylate-sodium—Erythema—Dactinomycin—melanoma	0.000708	0.00362	CcSEcCtD
Salicylate-sodium—Diarrhoea—Vemurafenib—melanoma	0.000699	0.00358	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Temozolomide—melanoma	0.000695	0.00355	CcSEcCtD
Salicylate-sodium—Tinnitus—Temozolomide—melanoma	0.000685	0.00351	CcSEcCtD
Salicylate-sodium—Arrhythmia—Carmustine—melanoma	0.00068	0.00348	CcSEcCtD
Salicylate-sodium—Dizziness—Vemurafenib—melanoma	0.000676	0.00346	CcSEcCtD
Salicylate-sodium—Erythema—Carmustine—melanoma	0.000662	0.00339	CcSEcCtD
Salicylate-sodium—Dehydration—Docetaxel—melanoma	0.000657	0.00336	CcSEcCtD
Salicylate-sodium—PTGS1—head—melanoma	0.00065	0.0219	CbGeAlD
Salicylate-sodium—Vomiting—Vemurafenib—melanoma	0.00065	0.00332	CcSEcCtD
Salicylate-sodium—Chest pain—Bleomycin—melanoma	0.000646	0.0033	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Docetaxel—melanoma	0.000645	0.0033	CcSEcCtD
Salicylate-sodium—Rash—Vemurafenib—melanoma	0.000644	0.0033	CcSEcCtD
Salicylate-sodium—Dermatitis—Vemurafenib—melanoma	0.000644	0.00329	CcSEcCtD
Salicylate-sodium—Headache—Vemurafenib—melanoma	0.00064	0.00327	CcSEcCtD
Salicylate-sodium—Erythema—Temozolomide—melanoma	0.00064	0.00327	CcSEcCtD
Salicylate-sodium—Dysgeusia—Temozolomide—melanoma	0.000627	0.00321	CcSEcCtD
Salicylate-sodium—Confusional state—Bleomycin—melanoma	0.000624	0.00319	CcSEcCtD
Salicylate-sodium—Vision blurred—Carmustine—melanoma	0.000624	0.00319	CcSEcCtD
Salicylate-sodium—PTGS2—head—melanoma	0.000621	0.0209	CbGeAlD
Salicylate-sodium—Anaphylactic shock—Bleomycin—melanoma	0.000619	0.00317	CcSEcCtD
Salicylate-sodium—Oedema—Bleomycin—melanoma	0.000619	0.00317	CcSEcCtD
Salicylate-sodium—Infection—Bleomycin—melanoma	0.000615	0.00315	CcSEcCtD
Salicylate-sodium—Dysphagia—Docetaxel—melanoma	0.000611	0.00312	CcSEcCtD
Salicylate-sodium—Nausea—Vemurafenib—melanoma	0.000607	0.0031	CcSEcCtD
Salicylate-sodium—Vision blurred—Temozolomide—melanoma	0.000603	0.00308	CcSEcCtD
Salicylate-sodium—Bronchospasm—Docetaxel—melanoma	0.000601	0.00307	CcSEcCtD
Salicylate-sodium—Magnesium salicylate—PTGS2—melanoma	0.000592	0.0512	CrCbGaD
Salicylate-sodium—Anorexia—Bleomycin—melanoma	0.00059	0.00302	CcSEcCtD
Salicylate-sodium—Hypotension—Bleomycin—melanoma	0.000579	0.00296	CcSEcCtD
Salicylate-sodium—Oedema—Dactinomycin—melanoma	0.000577	0.00295	CcSEcCtD
Salicylate-sodium—Convulsion—Carmustine—melanoma	0.000574	0.00293	CcSEcCtD
Salicylate-sodium—Infection—Dactinomycin—melanoma	0.000574	0.00293	CcSEcCtD
Salicylate-sodium—Palpitations—Temozolomide—melanoma	0.000566	0.00289	CcSEcCtD
Salicylate-sodium—Chest pain—Carmustine—melanoma	0.000564	0.00288	CcSEcCtD
Salicylate-sodium—Anxiety—Carmustine—melanoma	0.000562	0.00287	CcSEcCtD
Salicylate-sodium—Paraesthesia—Bleomycin—melanoma	0.000556	0.00284	CcSEcCtD
Salicylate-sodium—Weight increased—Docetaxel—melanoma	0.000556	0.00284	CcSEcCtD
Salicylate-sodium—Convulsion—Temozolomide—melanoma	0.000555	0.00284	CcSEcCtD
Salicylate-sodium—Dyspnoea—Bleomycin—melanoma	0.000552	0.00282	CcSEcCtD
Salicylate-sodium—Anorexia—Dactinomycin—melanoma	0.00055	0.00282	CcSEcCtD
Salicylate-sodium—Confusional state—Carmustine—melanoma	0.000545	0.00279	CcSEcCtD
Salicylate-sodium—Anxiety—Temozolomide—melanoma	0.000543	0.00278	CcSEcCtD
Salicylate-sodium—Oedema—Carmustine—melanoma	0.00054	0.00276	CcSEcCtD
Salicylate-sodium—Decreased appetite—Bleomycin—melanoma	0.000538	0.00275	CcSEcCtD
Salicylate-sodium—Infection—Carmustine—melanoma	0.000537	0.00275	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Docetaxel—melanoma	0.000537	0.00275	CcSEcCtD
Salicylate-sodium—Renal failure—Docetaxel—melanoma	0.000535	0.00274	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Docetaxel—melanoma	0.000534	0.00273	CcSEcCtD
Salicylate-sodium—Pain—Bleomycin—melanoma	0.00053	0.00271	CcSEcCtD
Salicylate-sodium—Magnesium salicylate—ALB—melanoma	0.000528	0.0456	CrCbGaD
Salicylate-sodium—Tachycardia—Carmustine—melanoma	0.000528	0.0027	CcSEcCtD
Salicylate-sodium—Confusional state—Temozolomide—melanoma	0.000527	0.00269	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Temozolomide—melanoma	0.000522	0.00267	CcSEcCtD
Salicylate-sodium—Oedema—Temozolomide—melanoma	0.000522	0.00267	CcSEcCtD
Salicylate-sodium—Infection—Temozolomide—melanoma	0.000519	0.00265	CcSEcCtD
Salicylate-sodium—Anorexia—Carmustine—melanoma	0.000515	0.00263	CcSEcCtD
Salicylate-sodium—Epistaxis—Docetaxel—melanoma	0.000514	0.00263	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Bleomycin—melanoma	0.00051	0.00261	CcSEcCtD
Salicylate-sodium—Hypotension—Carmustine—melanoma	0.000505	0.00258	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Temozolomide—melanoma	0.000505	0.00258	CcSEcCtD
Salicylate-sodium—Salsalate—PTGS2—melanoma	0.000503	0.0435	CrCbGaD
Salicylate-sodium—Decreased appetite—Dactinomycin—melanoma	0.000502	0.00257	CcSEcCtD
Salicylate-sodium—Fatigue—Dactinomycin—melanoma	0.000498	0.00255	CcSEcCtD
Salicylate-sodium—Anorexia—Temozolomide—melanoma	0.000498	0.00255	CcSEcCtD
Salicylate-sodium—Pain—Dactinomycin—melanoma	0.000494	0.00253	CcSEcCtD
Salicylate-sodium—Urticaria—Bleomycin—melanoma	0.000492	0.00252	CcSEcCtD
Salicylate-sodium—Body temperature increased—Bleomycin—melanoma	0.000489	0.0025	CcSEcCtD
Salicylate-sodium—Hepatitis—Docetaxel—melanoma	0.000489	0.0025	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Docetaxel—melanoma	0.000486	0.00249	CcSEcCtD
Salicylate-sodium—Paraesthesia—Carmustine—melanoma	0.000485	0.00248	CcSEcCtD
Salicylate-sodium—Dyspnoea—Carmustine—melanoma	0.000482	0.00246	CcSEcCtD
Salicylate-sodium—Somnolence—Carmustine—melanoma	0.000481	0.00246	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Dactinomycin—melanoma	0.000476	0.00243	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Dactinomycin—melanoma	0.000472	0.00241	CcSEcCtD
Salicylate-sodium—Decreased appetite—Carmustine—melanoma	0.00047	0.0024	CcSEcCtD
Salicylate-sodium—Paraesthesia—Temozolomide—melanoma	0.000469	0.0024	CcSEcCtD
Salicylate-sodium—Dyspnoea—Temozolomide—melanoma	0.000466	0.00238	CcSEcCtD
Salicylate-sodium—Somnolence—Temozolomide—melanoma	0.000464	0.00237	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Docetaxel—melanoma	0.000462	0.00236	CcSEcCtD
Salicylate-sodium—Pain—Carmustine—melanoma	0.000462	0.00236	CcSEcCtD
Salicylate-sodium—Constipation—Carmustine—melanoma	0.000462	0.00236	CcSEcCtD
Salicylate-sodium—Dyspepsia—Temozolomide—melanoma	0.00046	0.00235	CcSEcCtD
Salicylate-sodium—Abdominal pain—Dactinomycin—melanoma	0.000457	0.00233	CcSEcCtD
Salicylate-sodium—Body temperature increased—Dactinomycin—melanoma	0.000457	0.00233	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Bleomycin—melanoma	0.000456	0.00233	CcSEcCtD
Salicylate-sodium—PTGS1—lymph node—melanoma	0.000455	0.0153	CbGeAlD
Salicylate-sodium—Decreased appetite—Temozolomide—melanoma	0.000454	0.00232	CcSEcCtD
Salicylate-sodium—Fatigue—Temozolomide—melanoma	0.00045	0.0023	CcSEcCtD
Salicylate-sodium—Pain—Temozolomide—melanoma	0.000447	0.00228	CcSEcCtD
Salicylate-sodium—Constipation—Temozolomide—melanoma	0.000447	0.00228	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Carmustine—melanoma	0.000445	0.00228	CcSEcCtD
Salicylate-sodium—Asthenia—Bleomycin—melanoma	0.000444	0.00227	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Carmustine—melanoma	0.000442	0.00226	CcSEcCtD
Salicylate-sodium—Pruritus—Bleomycin—melanoma	0.000438	0.00224	CcSEcCtD
Salicylate-sodium—Mesalazine—PTGS2—melanoma	0.000437	0.0378	CrCbGaD
Salicylate-sodium—Arrhythmia—Docetaxel—melanoma	0.000437	0.00223	CcSEcCtD
Salicylate-sodium—PTGS2—lymph node—melanoma	0.000435	0.0147	CbGeAlD
Salicylate-sodium—Feeling abnormal—Temozolomide—melanoma	0.00043	0.0022	CcSEcCtD
Salicylate-sodium—Abdominal pain—Carmustine—melanoma	0.000427	0.00219	CcSEcCtD
Salicylate-sodium—Body temperature increased—Carmustine—melanoma	0.000427	0.00219	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Temozolomide—melanoma	0.000427	0.00218	CcSEcCtD
Salicylate-sodium—Erythema—Docetaxel—melanoma	0.000426	0.00218	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Dactinomycin—melanoma	0.000425	0.00218	CcSEcCtD
Salicylate-sodium—Dysgeusia—Docetaxel—melanoma	0.000417	0.00213	CcSEcCtD
Salicylate-sodium—Urticaria—Temozolomide—melanoma	0.000415	0.00212	CcSEcCtD
Salicylate-sodium—Asthenia—Dactinomycin—melanoma	0.000414	0.00212	CcSEcCtD
Salicylate-sodium—Abdominal pain—Temozolomide—melanoma	0.000413	0.00211	CcSEcCtD
Salicylate-sodium—Body temperature increased—Temozolomide—melanoma	0.000413	0.00211	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Carmustine—melanoma	0.000398	0.00204	CcSEcCtD
Salicylate-sodium—Diarrhoea—Dactinomycin—melanoma	0.000395	0.00202	CcSEcCtD
Salicylate-sodium—Vomiting—Bleomycin—melanoma	0.000394	0.00201	CcSEcCtD
Salicylate-sodium—Rash—Bleomycin—melanoma	0.00039	0.002	CcSEcCtD
Salicylate-sodium—Dermatitis—Bleomycin—melanoma	0.00039	0.00199	CcSEcCtD
Salicylate-sodium—Asthenia—Carmustine—melanoma	0.000388	0.00198	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Temozolomide—melanoma	0.000385	0.00197	CcSEcCtD
Salicylate-sodium—Syncope—Docetaxel—melanoma	0.000382	0.00195	CcSEcCtD
Salicylate-sodium—Palpitations—Docetaxel—melanoma	0.000376	0.00192	CcSEcCtD
Salicylate-sodium—Acetylsalicylic acid—PTGS2—melanoma	0.000376	0.0325	CrCbGaD
Salicylate-sodium—Asthenia—Temozolomide—melanoma	0.000375	0.00192	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Docetaxel—melanoma	0.000374	0.00191	CcSEcCtD
Salicylate-sodium—Diarrhoea—Carmustine—melanoma	0.00037	0.00189	CcSEcCtD
Salicylate-sodium—Pruritus—Temozolomide—melanoma	0.00037	0.00189	CcSEcCtD
Salicylate-sodium—Convulsion—Docetaxel—melanoma	0.000369	0.00189	CcSEcCtD
Salicylate-sodium—Nausea—Bleomycin—melanoma	0.000368	0.00188	CcSEcCtD
Salicylate-sodium—Vomiting—Dactinomycin—melanoma	0.000367	0.00188	CcSEcCtD
Salicylate-sodium—Rash—Dactinomycin—melanoma	0.000364	0.00186	CcSEcCtD
Salicylate-sodium—Chest pain—Docetaxel—melanoma	0.000362	0.00185	CcSEcCtD
Salicylate-sodium—Dizziness—Carmustine—melanoma	0.000357	0.00183	CcSEcCtD
Salicylate-sodium—Diarrhoea—Temozolomide—melanoma	0.000357	0.00183	CcSEcCtD
Salicylate-sodium—Confusional state—Docetaxel—melanoma	0.00035	0.00179	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Docetaxel—melanoma	0.000347	0.00178	CcSEcCtD
Salicylate-sodium—Oedema—Docetaxel—melanoma	0.000347	0.00178	CcSEcCtD
Salicylate-sodium—Dizziness—Temozolomide—melanoma	0.000345	0.00177	CcSEcCtD
Salicylate-sodium—Infection—Docetaxel—melanoma	0.000345	0.00176	CcSEcCtD
Salicylate-sodium—Vomiting—Carmustine—melanoma	0.000344	0.00176	CcSEcCtD
Salicylate-sodium—Nausea—Dactinomycin—melanoma	0.000343	0.00175	CcSEcCtD
Salicylate-sodium—Shock—Docetaxel—melanoma	0.000342	0.00175	CcSEcCtD
Salicylate-sodium—Rash—Carmustine—melanoma	0.000341	0.00174	CcSEcCtD
Salicylate-sodium—Dermatitis—Carmustine—melanoma	0.00034	0.00174	CcSEcCtD
Salicylate-sodium—Tachycardia—Docetaxel—melanoma	0.000339	0.00173	CcSEcCtD
Salicylate-sodium—Headache—Carmustine—melanoma	0.000339	0.00173	CcSEcCtD
Salicylate-sodium—Acetylsalicylic acid—ALB—melanoma	0.000335	0.029	CrCbGaD
Salicylate-sodium—Vomiting—Temozolomide—melanoma	0.000332	0.0017	CcSEcCtD
Salicylate-sodium—Anorexia—Docetaxel—melanoma	0.000331	0.00169	CcSEcCtD
Salicylate-sodium—Rash—Temozolomide—melanoma	0.000329	0.00168	CcSEcCtD
Salicylate-sodium—Dermatitis—Temozolomide—melanoma	0.000329	0.00168	CcSEcCtD
Salicylate-sodium—Headache—Temozolomide—melanoma	0.000327	0.00167	CcSEcCtD
Salicylate-sodium—Hypotension—Docetaxel—melanoma	0.000325	0.00166	CcSEcCtD
Salicylate-sodium—Nausea—Carmustine—melanoma	0.000321	0.00164	CcSEcCtD
Salicylate-sodium—Acetylsalicylic acid—ABCB1—melanoma	0.00032	0.0276	CrCbGaD
Salicylate-sodium—Paraesthesia—Docetaxel—melanoma	0.000312	0.0016	CcSEcCtD
Salicylate-sodium—Nausea—Temozolomide—melanoma	0.00031	0.00159	CcSEcCtD
Salicylate-sodium—Salicylic acid—PTGS2—melanoma	0.00031	0.0268	CrCbGaD
Salicylate-sodium—Dyspnoea—Docetaxel—melanoma	0.00031	0.00158	CcSEcCtD
Salicylate-sodium—Somnolence—Docetaxel—melanoma	0.000309	0.00158	CcSEcCtD
Salicylate-sodium—Dyspepsia—Docetaxel—melanoma	0.000306	0.00156	CcSEcCtD
Salicylate-sodium—Decreased appetite—Docetaxel—melanoma	0.000302	0.00154	CcSEcCtD
Salicylate-sodium—Fatigue—Docetaxel—melanoma	0.000299	0.00153	CcSEcCtD
Salicylate-sodium—Pain—Docetaxel—melanoma	0.000297	0.00152	CcSEcCtD
Salicylate-sodium—Constipation—Docetaxel—melanoma	0.000297	0.00152	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Docetaxel—melanoma	0.000286	0.00146	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Docetaxel—melanoma	0.000284	0.00145	CcSEcCtD
Salicylate-sodium—Salicylic acid—ALB—melanoma	0.000276	0.0238	CrCbGaD
Salicylate-sodium—Body temperature increased—Docetaxel—melanoma	0.000275	0.0014	CcSEcCtD
Salicylate-sodium—Abdominal pain—Docetaxel—melanoma	0.000275	0.0014	CcSEcCtD
Salicylate-sodium—Salicylic acid—ABCB1—melanoma	0.000263	0.0228	CrCbGaD
Salicylate-sodium—Hypersensitivity—Docetaxel—melanoma	0.000256	0.00131	CcSEcCtD
Salicylate-sodium—Asthenia—Docetaxel—melanoma	0.000249	0.00127	CcSEcCtD
Salicylate-sodium—Pruritus—Docetaxel—melanoma	0.000246	0.00126	CcSEcCtD
Salicylate-sodium—Diarrhoea—Docetaxel—melanoma	0.000238	0.00122	CcSEcCtD
Salicylate-sodium—Dizziness—Docetaxel—melanoma	0.00023	0.00117	CcSEcCtD
Salicylate-sodium—Vomiting—Docetaxel—melanoma	0.000221	0.00113	CcSEcCtD
Salicylate-sodium—Rash—Docetaxel—melanoma	0.000219	0.00112	CcSEcCtD
Salicylate-sodium—Dermatitis—Docetaxel—melanoma	0.000219	0.00112	CcSEcCtD
Salicylate-sodium—Headache—Docetaxel—melanoma	0.000218	0.00111	CcSEcCtD
Salicylate-sodium—Nausea—Docetaxel—melanoma	0.000206	0.00106	CcSEcCtD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—NRAS—melanoma	0.000145	0.00265	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—PTGS2—melanoma	0.00014	0.00255	CbGpPWpGaD
Salicylate-sodium—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—melanoma	0.000138	0.00252	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000138	0.00251	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—RAC1—melanoma	0.000137	0.0025	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—MYC—melanoma	0.000136	0.00247	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—melanoma	0.000133	0.00241	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—EGFR—melanoma	0.000133	0.00241	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000131	0.00239	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CDK2—melanoma	0.00013	0.00237	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000129	0.00235	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—ALB—melanoma	0.000127	0.00232	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—TNF—melanoma	0.000126	0.0023	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TLR4—melanoma	0.000126	0.00229	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—KRAS—melanoma	0.000125	0.00228	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—CDKN2A—melanoma	0.000124	0.00225	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CDK4—melanoma	0.000123	0.00224	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—NFKB1—melanoma	0.000122	0.00222	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—BCL2—melanoma	0.000122	0.00221	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ACER3—melanoma	0.000121	0.00221	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—ICAM1—melanoma	0.000121	0.0022	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—NOS2—melanoma	0.00012	0.00218	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—melanoma	0.000118	0.00215	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—CD4—melanoma	0.000116	0.00212	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—IFNG—melanoma	0.000116	0.00211	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MYO7A—melanoma	0.000115	0.00209	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	0.000112	0.00204	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—UGT2B10—melanoma	0.000111	0.00202	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.00011	0.00199	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—CDKN1B—melanoma	0.000109	0.00199	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—melanoma	0.000109	0.00199	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000109	0.00199	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—RB1—melanoma	0.000107	0.00195	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—HRAS—melanoma	0.000106	0.00194	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	0.000105	0.00191	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—CCND1—melanoma	0.000104	0.0019	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—HS3ST5—melanoma	0.000103	0.00188	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	0.000103	0.00187	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000102	0.00186	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	0.000102	0.00185	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—CDKN1A—melanoma	0.000101	0.00184	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	0.000101	0.00183	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	9.87e-05	0.0018	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HS3ST5—melanoma	9.78e-05	0.00178	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	9.69e-05	0.00176	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—NFKB1—melanoma	9.66e-05	0.00176	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ACER3—melanoma	9.63e-05	0.00175	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—melanoma	9.52e-05	0.00173	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—TNF—melanoma	9.46e-05	0.00172	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	9.33e-05	0.0017	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IFNG—melanoma	9.18e-05	0.00167	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—NRAS—melanoma	8.99e-05	0.00164	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	8.86e-05	0.00161	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—UGT2B10—melanoma	8.81e-05	0.0016	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	8.7e-05	0.00158	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CXCL8—melanoma	8.54e-05	0.00155	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—melanoma	8.41e-05	0.00153	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	8.38e-05	0.00153	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—MYC—melanoma	8.37e-05	0.00152	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CDKN1B—melanoma	8.34e-05	0.00152	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	8.3e-05	0.00151	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—HS3ST5—melanoma	8.19e-05	0.00149	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CASP3—melanoma	8.17e-05	0.00149	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL2—melanoma	8.16e-05	0.00149	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CCND1—melanoma	7.95e-05	0.00145	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—APC—melanoma	7.89e-05	0.00144	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PLCB4—melanoma	7.82e-05	0.00142	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—melanoma	7.79e-05	0.00142	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—KRAS—melanoma	7.73e-05	0.00141	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—MMP9—melanoma	7.72e-05	0.00141	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—FASN—melanoma	7.67e-05	0.0014	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—IL6—melanoma	7.64e-05	0.00139	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—TNF—melanoma	7.51e-05	0.00137	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PIP4K2A—melanoma	7.35e-05	0.00134	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—SLC6A11—melanoma	7.35e-05	0.00134	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	7.34e-05	0.00134	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	7.22e-05	0.00131	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—MTAP—melanoma	7.15e-05	0.0013	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	6.99e-05	0.00127	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	6.98e-05	0.00127	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TRRAP—melanoma	6.97e-05	0.00127	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CUL3—melanoma	6.97e-05	0.00127	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—AKR1B10—melanoma	6.78e-05	0.00123	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	6.64e-05	0.00121	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	6.59e-05	0.0012	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—HRAS—melanoma	6.57e-05	0.0012	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—MAPK3—melanoma	6.56e-05	0.00119	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—MYC—melanoma	6.38e-05	0.00116	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PHGDH—melanoma	6.37e-05	0.00116	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—LUM—melanoma	6.37e-05	0.00116	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	6.3e-05	0.00115	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—HPSE—melanoma	6.25e-05	0.00114	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—MAPK1—melanoma	6.24e-05	0.00114	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—EGFR—melanoma	6.24e-05	0.00114	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	6.21e-05	0.00113	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PLCB4—melanoma	6.21e-05	0.00113	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CUBN—melanoma	6.13e-05	0.00112	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	6.12e-05	0.00112	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—FASN—melanoma	6.09e-05	0.00111	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—IL6—melanoma	6.06e-05	0.0011	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—LUM—melanoma	6.04e-05	0.0011	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TNF—melanoma	5.94e-05	0.00108	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—SDHD—melanoma	5.92e-05	0.00108	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CSPG4—melanoma	5.92e-05	0.00108	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—BSG—melanoma	5.92e-05	0.00108	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HPSE—melanoma	5.92e-05	0.00108	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PIP4K2A—melanoma	5.83e-05	0.00106	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SLC6A11—melanoma	5.83e-05	0.00106	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CUBN—melanoma	5.81e-05	0.00106	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GPAM—melanoma	5.74e-05	0.00104	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—MTAP—melanoma	5.68e-05	0.00103	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	5.67e-05	0.00103	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CSPG4—melanoma	5.62e-05	0.00102	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	5.56e-05	0.00101	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	5.55e-05	0.00101	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—RPS3—melanoma	5.52e-05	0.00101	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SKI—melanoma	5.44e-05	0.00099	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	5.41e-05	0.000985	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	5.36e-05	0.000976	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TP53—melanoma	5.24e-05	0.000954	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	5.23e-05	0.000953	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	5.22e-05	0.000951	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	5.2e-05	0.000946	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PHGDH—melanoma	5.06e-05	0.000921	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—LUM—melanoma	5.06e-05	0.000921	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—HPSE—melanoma	4.96e-05	0.000903	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PLA2G6—melanoma	4.88e-05	0.000888	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CUBN—melanoma	4.87e-05	0.000887	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL6—melanoma	4.79e-05	0.000873	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	4.72e-05	0.000859	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SDHD—melanoma	4.7e-05	0.000856	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CSPG4—melanoma	4.7e-05	0.000856	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—BSG—melanoma	4.7e-05	0.000856	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GPAM—melanoma	4.55e-05	0.000829	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HDAC6—melanoma	4.49e-05	0.000818	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	4.46e-05	0.000812	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—VCAN—melanoma	4.38e-05	0.000798	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—melanoma	4.34e-05	0.00079	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NPPA—melanoma	4.26e-05	0.000775	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	4.24e-05	0.000773	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	4.24e-05	0.000773	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—VCAN—melanoma	4.15e-05	0.000756	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.15e-05	0.000755	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—WNT5A—melanoma	4.12e-05	0.000751	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—melanoma	4.04e-05	0.000736	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	4.01e-05	0.00073	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PPARG—melanoma	4e-05	0.000729	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PLA2G6—melanoma	3.87e-05	0.000705	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP17A1—melanoma	3.7e-05	0.000673	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	3.68e-05	0.000671	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.65e-05	0.000664	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—ALB—melanoma	3.6e-05	0.000656	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—melanoma	3.56e-05	0.000649	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GNA11—melanoma	3.49e-05	0.000636	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—VCAN—melanoma	3.48e-05	0.000634	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—FASN—melanoma	3.42e-05	0.000622	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—SLC5A5—melanoma	3.36e-05	0.000612	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—GAB2—melanoma	3.31e-05	0.000603	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.29e-05	0.0006	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CD44—melanoma	3.25e-05	0.000591	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GNAQ—melanoma	3.25e-05	0.000591	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—FASN—melanoma	3.24e-05	0.00059	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.18e-05	0.000579	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.18e-05	0.000579	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.15e-05	0.000574	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP1B1—melanoma	3.11e-05	0.000567	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HDAC2—melanoma	3.11e-05	0.000567	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CXCR4—melanoma	3.11e-05	0.000567	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—FOXO4—melanoma	3.11e-05	0.000567	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CD44—melanoma	3.08e-05	0.00056	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	3.01e-05	0.000548	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP17A1—melanoma	2.93e-05	0.000535	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.89e-05	0.000527	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	2.86e-05	0.00052	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—AKT3—melanoma	2.84e-05	0.000517	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GNA11—melanoma	2.77e-05	0.000505	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.75e-05	0.0005	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—FASN—melanoma	2.71e-05	0.000494	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SLC5A5—melanoma	2.67e-05	0.000486	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GNAQ—melanoma	2.58e-05	0.000469	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CD44—melanoma	2.58e-05	0.000469	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ABCB1—melanoma	2.56e-05	0.000467	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.52e-05	0.00046	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ERBB4—melanoma	2.51e-05	0.000457	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CDKN2B—melanoma	2.49e-05	0.000453	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP1B1—melanoma	2.47e-05	0.00045	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CD86—melanoma	2.4e-05	0.000438	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PRKCA—melanoma	2.36e-05	0.00043	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ERCC2—melanoma	2.34e-05	0.000426	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—FGF1—melanoma	2.33e-05	0.000425	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PDGFRA—melanoma	2.26e-05	0.000411	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PRKCA—melanoma	2.24e-05	0.000407	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ERCC2—melanoma	2.22e-05	0.000404	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MAP2K2—melanoma	2.19e-05	0.000398	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.18e-05	0.000397	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TERT—melanoma	2.08e-05	0.000379	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HLA-A—melanoma	2.08e-05	0.000379	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—RAC1—melanoma	2.07e-05	0.000377	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ABCB1—melanoma	2.03e-05	0.00037	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HIF1A—melanoma	1.99e-05	0.000362	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.94e-05	0.000353	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PRKCA—melanoma	1.87e-05	0.000341	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ERCC2—melanoma	1.86e-05	0.000338	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PIK3CG—melanoma	1.85e-05	0.000336	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NOS2—melanoma	1.81e-05	0.000329	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NOTCH1—melanoma	1.79e-05	0.000326	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PPARG—melanoma	1.78e-05	0.000325	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CD80—melanoma	1.75e-05	0.000319	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—APC—melanoma	1.75e-05	0.000319	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—KIT—melanoma	1.75e-05	0.000319	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—EGF—melanoma	1.73e-05	0.000315	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—BRAF—melanoma	1.65e-05	0.0003	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PIK3CD—melanoma	1.62e-05	0.000296	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ALB—melanoma	1.6e-05	0.000292	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MAP2K1—melanoma	1.55e-05	0.000282	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PIK3CD—melanoma	1.54e-05	0.00028	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.54e-05	0.00028	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—FGF2—melanoma	1.47e-05	0.000268	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PIK3CG—melanoma	1.47e-05	0.000267	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PIK3CB—melanoma	1.42e-05	0.000258	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PPARG—melanoma	1.42e-05	0.000258	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PTGS2—melanoma	1.4e-05	0.000255	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MDM2—melanoma	1.38e-05	0.000251	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ERBB2—melanoma	1.36e-05	0.000248	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PIK3CB—melanoma	1.34e-05	0.000244	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CD4—melanoma	1.34e-05	0.000244	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PIK3CD—melanoma	1.29e-05	0.000235	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALB—melanoma	1.27e-05	0.000232	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CDKN1B—melanoma	1.26e-05	0.000229	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PTEN—melanoma	1.22e-05	0.000223	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CTNNB1—melanoma	1.19e-05	0.000217	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CDKN1A—melanoma	1.16e-05	0.000212	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PTEN—melanoma	1.16e-05	0.000211	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PIK3CB—melanoma	1.12e-05	0.000205	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—STAT3—melanoma	1.04e-05	0.000189	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NRAS—melanoma	1.03e-05	0.000188	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MAPK3—melanoma	9.91e-06	0.00018	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PTEN—melanoma	9.71e-06	0.000177	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MYC—melanoma	9.64e-06	0.000175	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MAPK1—melanoma	9.43e-06	0.000172	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—EGFR—melanoma	9.42e-06	0.000172	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—KRAS—melanoma	8.9e-06	0.000162	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PIK3CA—melanoma	8.63e-06	0.000157	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PIK3CA—melanoma	8.18e-06	0.000149	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HRAS—melanoma	7.57e-06	0.000138	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—IL6—melanoma	7.24e-06	0.000132	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—AKT1—melanoma	7.05e-06	0.000128	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PIK3CA—melanoma	6.85e-06	0.000125	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—AKT1—melanoma	6.68e-06	0.000122	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—AKT1—melanoma	5.6e-06	0.000102	CbGpPWpGaD
